Assay News and Research

RSS
Cell-based tests reveal no activity in cells exposed to vapour from Vype ePen

Cell-based tests reveal no activity in cells exposed to vapour from Vype ePen

Advion introduces new metal catalyst reaction monitoring technique for CMS product line

Advion introduces new metal catalyst reaction monitoring technique for CMS product line

Researchers aim to design a better male contraceptive pill

Researchers aim to design a better male contraceptive pill

New microfluidic biosensor can identify white blood cells quickly for AIDS diagnosis

New microfluidic biosensor can identify white blood cells quickly for AIDS diagnosis

Scientists discover novel drug candidate to treat breast cancer, lung cancer and melanoma

Scientists discover novel drug candidate to treat breast cancer, lung cancer and melanoma

Low cost, easy-to-use test could help reduce TB death rate of HIV patients in sub-Saharan Africa

Low cost, easy-to-use test could help reduce TB death rate of HIV patients in sub-Saharan Africa

VolitionRx's NuQ blood test accurately detects 86% of subjects with Idiopathic Pulmonary Fibrosis

VolitionRx's NuQ blood test accurately detects 86% of subjects with Idiopathic Pulmonary Fibrosis

Johns Hopkins Greenberg Bladder Cancer Institute awards grants for 10 bladder cancer research projects

Johns Hopkins Greenberg Bladder Cancer Institute awards grants for 10 bladder cancer research projects

Renishaw inVia to support development of nanomolecular probes in Kircher Laboratory at Memorial Sloan Kettering

Renishaw inVia to support development of nanomolecular probes in Kircher Laboratory at Memorial Sloan Kettering

Oncimmune partners with Stroke Detection Plus to offer EarlyCDT-Lung test

Oncimmune partners with Stroke Detection Plus to offer EarlyCDT-Lung test

FDA clearance expands clinical claims of Thermo Scientific B•R•A•H•M•S PCT biomarker for sepsis risk assessment

FDA clearance expands clinical claims of Thermo Scientific B•R•A•H•M•S PCT biomarker for sepsis risk assessment

Researchers discover new biomarker that puts patients at higher risk for metastasis of uveal melanoma

Researchers discover new biomarker that puts patients at higher risk for metastasis of uveal melanoma

MD Biosciences launches rapid assay to detect Zika virus

MD Biosciences launches rapid assay to detect Zika virus

Luminex collaborates with University of São Paulo to validate multi-analyte Zika virus assay

Luminex collaborates with University of São Paulo to validate multi-analyte Zika virus assay

Baxalta seeks FDA approval for ADYNOVATE to treat children with hemophilia A and for use in surgical settings

Baxalta seeks FDA approval for ADYNOVATE to treat children with hemophilia A and for use in surgical settings

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

CHLA, Thermo Fisher Scientific agree to develop NGS-based panel for pediatric cancer research

CHLA, Thermo Fisher Scientific agree to develop NGS-based panel for pediatric cancer research

DEK gene present in plasma can help predict outcomes for patients with head and neck cancer

DEK gene present in plasma can help predict outcomes for patients with head and neck cancer

Confirming nasogastric tube placement through an assay? An interview with Ian Fotheringham

Confirming nasogastric tube placement through an assay? An interview with Ian Fotheringham

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.